Matinas BioPharma Holdings Inc (MTNB) Short Interest Update
Matinas BioPharma Holdings Inc (NYSE:MTNB) was the target of a large decline in short interest in July. As of July 31st, there was short interest totalling 3,548,526 shares, a decline of 15.0% from the July 14th total of 4,176,369 shares. Based on an average trading volume of 276,741 shares, the days-to-cover ratio is currently 12.8 days. Currently, 5.4% of the company’s stock are sold short.
Shares of Matinas BioPharma Holdings (MTNB) opened at 1.36 on Thursday. The stock’s market cap is $124.30 million. The company’s 50-day moving average is $1.79 and its 200 day moving average is $2.59. Matinas BioPharma Holdings has a 1-year low of $0.63 and a 1-year high of $3.99.
Matinas BioPharma Holdings Company Profile
Matinas BioPharma Holdings, Inc is a clinical-stage biopharmaceutical company. The Company is engaged in identifying and developing therapeutics for the treatment of serious and life-threatening infections. It is engaged in developing a pipeline of product and development candidates, with an initial focus on serious fungal and bacterial infections.
Receive News & Ratings for Matinas BioPharma Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Matinas BioPharma Holdings Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.